CoChat

The First N-terminal Amino Acids of α-Synuclein Are Essential for α-Helical Structure Formation In Vitro and Membrane Binding in Yeast

Vamvaca, Katherina, Volles, Michael J., Lansbury, Peter T. · 2009 · Journal of Molecular Biology
Cited by 144

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jmb.2009.03.021

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 41

  1. Spillantini, 1997, Alpha-synuclein in Lewy bodies, Nature, 388, 839, 10.1038/42166 · DOI · Paper page
  2. Weinreb, 1996, NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded, Biochemistry, 35, 13709, 10.1021/bi961799n · DOI · Paper page
  3. Conway, 2000, Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid, Biochemistry, 39, 2552, 10.1021/bi991447r · DOI · Paper page
  4. Davidson, 1998, Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes, J. Biol. Chem., 273, 9443, 10.1074/jbc.273.16.9443 · DOI · Paper page
  5. Ulmer, 2005, Structure and dynamics of micelle-bound human α-synuclein, J. Biol. Chem., 280, 9595, 10.1074/jbc.M411805200 · DOI · Paper page
  6. Georgieva, 2008, Membrane-bound α-synuclein forms an extended helix: long-distance pulsed ESR measurements using vesicles, bicelles, and rodlike micelles, J. Am. Chem. Soc., 130, 12856, 10.1021/ja804517m · DOI · Paper page
  7. Volles, 2003, Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease, Biochemistry, 42, 7871, 10.1021/bi030086j · DOI · Paper page
  8. Conway, 2000, Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy, Proc. Natl Acad. Sci. USA, 97, 571, 10.1073/pnas.97.2.571 · DOI · Paper page
  9. Lashuel, 2002, Neurodegenerative disease: amyloid pores from pathogenic mutations, Nature, 418, 291, 10.1038/418291a · DOI · Paper page
  10. Volles, 2002, Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism, Biochemistry, 41, 4595, 10.1021/bi0121353 · DOI · Paper page
  11. Volles, 2007, Relationships between the sequence of alpha-synuclein and its membrane affinity, fibrillization propensity, and yeast toxicity, J. Mol. Biol., 366, 1510, 10.1016/j.jmb.2006.12.044 · DOI · Paper page
  12. Outeiro, 2003, Yeast cells provide insight into alpha-synuclein biology and pathobiology, Science, 302, 1772, 10.1126/science.1090439 · DOI · Paper page
  13. Fortin, 2005, Neural activity controls the synaptic accumulation of α-synuclein, J. Neurosci., 25, 10913, 10.1523/JNEUROSCI.2922-05.2005 · DOI · Paper page
  14. Kim, 2006, A novel mechanism of interaction between alpha-synuclein and biological membranes, J. Mol. Biol., 360, 386, 10.1016/j.jmb.2006.05.004 · DOI
  15. Jensen, 1998, Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation, J. Biol. Chem., 273, 26292, 10.1074/jbc.273.41.26292 · DOI · Paper page
  16. Stefanis, 2001, Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death, J. Neurosci., 21, 9549, 10.1523/JNEUROSCI.21-24-09549.2001 · DOI
  17. Tanaka, 2001, Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis, Hum. Mol. Genet., 10, 919, 10.1093/hmg/10.9.919 · DOI · Paper page
  18. Snyder, 2003, Aggregated and monomeric alpha-synuclein bind to the S6′ proteasomal protein and inhibit proteasomal function, J. Biol. Chem., 278, 11753, 10.1074/jbc.M208641200 · DOI · Paper page
  19. Cooper, 2006, Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models, Science, 313, 324, 10.1126/science.1129462 · DOI · Paper page
  20. Cole, 2002, Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein, J. Biol. Chem., 277, 6344, 10.1074/jbc.M108414200 · DOI · Paper page
  21. Kim, 2002, Structural and functional implications of C-terminal regions of alpha-synuclein, Biochemistry, 41, 13782, 10.1021/bi026284c · DOI · Paper page
  22. Li, 2005, Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations, Proc. Natl Acad. Sci. USA, 102, 2162, 10.1073/pnas.0406976102 · DOI · Paper page
  23. Ueda, 1994, Tissue-dependent alternative splicing of mRNA for NACP, the precursor of non-A beta component of Alzheimer's disease amyloid, Biochem. Biophys. Res. Commun., 205, 1366, 10.1006/bbrc.1994.2816 · DOI
  24. Murray, 2003, Role of alpha-synuclein carboxy-terminus on fibril formation in vitro, Biochemistry, 42, 8530, 10.1021/bi027363r · DOI · Paper page
  25. Kanda, 2000, Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation, Neuroscience, 97, 279, 10.1016/S0306-4522(00)00077-4 · DOI
  26. Bodles, 2001, Identification of the region of non-Abeta component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity, J. Neurochem., 78, 384, 10.1046/j.1471-4159.2001.00408.x · DOI
  27. Periquet, 2007, Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo, J. Neurosci., 27, 3338, 10.1523/JNEUROSCI.0285-07.2007 · DOI · Paper page
  28. Wurth, 2002, Mutations that reduce aggregation of the Alzheimer's Abeta42 peptide: an unbiased search for the sequence determinants of Abeta amyloidogenesis, J. Mol. Biol., 319, 1279, 10.1016/S0022-2836(02)00399-6 · DOI · Paper page
  29. Kessler, 2003, The N-terminal repeat domain of alpha-synuclein inhibits beta-sheet and amyloid fibril formation, Biochemistry, 42, 672, 10.1021/bi020429y · DOI · Paper page
  30. Zabrocki, 2008, Phosphorylation, lipid raft interaction and traffic of alpha-synuclein in a yeast model for Parkinson, Biochim. Biophys. Acta, 1783, 1767, 10.1016/j.bbamcr.2008.06.010 · DOI
  31. Polevoda, 2003, N-terminal acetyltransferases and sequence requirements for N-terminal acetylation of eukaryotic proteins, J. Mol. Biol., 325, 595, 10.1016/S0022-2836(02)01269-X · DOI · Paper page
  32. Hol, 1985, The role of the α-helix dipole in protein function and structure, Prog. Biophys. Mol. Biol., 45, 149, 10.1016/0079-6107(85)90001-X · DOI · Paper page
  33. Soper, 2008, alpha-Synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae, Mol. Biol. Cell, 19, 1093, 10.1091/mbc.E07-08-0827 · DOI · Paper page
  34. Brookes, 1994, Synuclein proteins and Alzheimer's disease, Trends Neurosci., 17, 404, 10.1016/0166-2236(94)90013-2 · DOI
  35. Han, 1995, The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease?, Chem. Biol., 2, 163, 10.1016/1074-5521(95)90071-3 · DOI · Paper page
  36. Bodner, 2006, Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases, Proc. Natl Acad. Sci. USA, 103, 4246, 10.1073/pnas.0511256103 · DOI · Paper page
  37. Munishkina, 2003, Conformational behavior and aggregation of alpha-synuclein in organic solvents: modeling the effects of membranes, Biochemistry, 42, 2720, 10.1021/bi027166s · DOI · Paper page
  38. Sreerama, 2000, Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set, Anal. Biochem., 287, 252, 10.1006/abio.2000.4880 · DOI · Paper page
  39. Bisaglia, 2005, A topological model of the interaction between alpha-synuclein and sodium dodecyl sulfate micelles, Biochemistry, 44, 329, 10.1021/bi048448q · DOI
  40. Jo, 2002, Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein, J. Mol. Biol., 315, 799, 10.1006/jmbi.2001.5269 · DOI · Paper page
  41. Stemmer, 1994, DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution, Proc. Natl Acad. Sci. USA, 91, 10747, 10.1073/pnas.91.22.10747 · DOI · Paper page

Cited by

See all 144

Metadata

Authors
Vamvaca, K., Volles, M. J., & Lansbury, P. T.
Venue
Journal of Molecular Biology
Publisher
Elsevier BV
Published
2009-06
Volume
389
Issue
2
Pages
413-424
ISSN
0022-2836
Cited by
144
References
1
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.